entity

HMGCS2/CPT1A

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HMGCS2/CPT1A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
1Hypotheses
1Analyses
2Outgoing
1Incoming
1Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
neurodegenerationassociated_withdisease0.40
neurodegenerationimplicated_indisease0.40

Incoming (1)

SourceRelationTypeStr
h-edfd6c89targetshypothesis0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Dual-Phase Medium-Chain Triglyceride Intervention 0.622 neurodegeneration How do astrocyte-neuron metabolic intera

Mentioning Analyses (1)

Scientific analyses that reference this entity

How do astrocyte-neuron metabolic interactions change during disease progression

neurodegeneration | 2026-04-04 | 3 hypotheses Top: 0.646

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
High fat diet aging study in CPT1A knockout mice validation kidney aging and metabolic dys 0.850 0.00 conditional CPT1A knockout mic proposed N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

How do astrocyte-neuron metabolic interactions change during disease progression

closed · Rounds: 4 · Score: 0.93 · 2026-04-04